Global Injectable Anticoagulants Market Research Report 2021 Professional Edition

  • Published Date : 27-10-2021
  • Pages : 140
  • Report Id : 30259
  • Categories : Healthcare

The global Injectable Anticoagulants market was valued at 568.22 Million USD in 2021 and will grow with a CAGR of 2.9% from 2021 to 2027, based on Stats and Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin ], enoxaparin [Lovenox ]) and factor Xa inhibitors (fondaparinux [Arixtra ]).In the last several years, global market of injectable anticoagulants developed slowly. In 2016, global revenue of injectable anticoagulants is nearly 5300 M USD. And the global growth rate is slow. The classification of injectable anticoagulants includes LMWH, DTI and other, and the proportion of LMWH in 2016 is about 55%, and the proportion is in decreasing trend from 2012 to 2016. Injectable anticoagulants are widely used for VTE, ACS/MI, AF and other field. The most proportion of injectable anticoagulants used to treat AF, and the revenue in 2016 is 3400 M USD.
By Market Verdors:
Sanofi
Genentech (Roche)
Boehringer Ingelheim
Pfizer
The Medicines Company
Aspen
Otsuka

By Types:
Low-molecular-weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)

By Applications:
VTE
ACS/MI
AF

Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.


1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Injectable Anticoagulants Revenue
1.4 Market Analysis by Type
1.4.1 Global Injectable Anticoagulants Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Low-molecular-weight Heparin (LMWH)
1.4.3 Direct Thrombin Inhibitor (DTI)
1.5 Market by Application
1.5.1 Global Injectable Anticoagulants Market Share by Application: 2021-2027
1.5.2 VTE
1.5.3 ACS/MI
1.5.4 AF
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Injectable Anticoagulants Market
1.8.1 Global Injectable Anticoagulants Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Injectable Anticoagulants Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Injectable Anticoagulants Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Injectable Anticoagulants Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Injectable Anticoagulants Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Injectable Anticoagulants Sales Volume Market Share by Region (2016-2021)
3.2 Global Injectable Anticoagulants Sales Revenue Market Share by Region (2016-2021)
3.3 North America Injectable Anticoagulants Sales Volume
3.3.1 North America Injectable Anticoagulants Sales Volume Growth Rate (2016-2021)
3.3.2 North America Injectable Anticoagulants Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Injectable Anticoagulants Sales Volume
3.4.1 East Asia Injectable Anticoagulants Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Injectable Anticoagulants Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Injectable Anticoagulants Sales Volume (2016-2021)
3.5.1 Europe Injectable Anticoagulants Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Injectable Anticoagulants Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Injectable Anticoagulants Sales Volume (2016-2021)
3.6.1 South Asia Injectable Anticoagulants Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Injectable Anticoagulants Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Injectable Anticoagulants Sales Volume (2016-2021)
3.7.1 Southeast Asia Injectable Anticoagulants Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Injectable Anticoagulants Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Injectable Anticoagulants Sales Volume (2016-2021)
3.8.1 Middle East Injectable Anticoagulants Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Injectable Anticoagulants Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Injectable Anticoagulants Sales Volume (2016-2021)
3.9.1 Africa Injectable Anticoagulants Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Injectable Anticoagulants Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Injectable Anticoagulants Sales Volume (2016-2021)
3.10.1 Oceania Injectable Anticoagulants Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Injectable Anticoagulants Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Injectable Anticoagulants Sales Volume (2016-2021)
3.11.1 South America Injectable Anticoagulants Sales Volume Growth Rate (2016-2021)
3.11.2 South America Injectable Anticoagulants Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Injectable Anticoagulants Sales Volume (2016-2021)
3.12.1 Rest of the World Injectable Anticoagulants Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Injectable Anticoagulants Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Injectable Anticoagulants Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Injectable Anticoagulants Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Injectable Anticoagulants Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Injectable Anticoagulants Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Injectable Anticoagulants Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Injectable Anticoagulants Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Injectable Anticoagulants Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Injectable Anticoagulants Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Injectable Anticoagulants Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Injectable Anticoagulants Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Injectable Anticoagulants Sales Volume Market Share by Type (2016-2021)
14.2 Global Injectable Anticoagulants Sales Revenue Market Share by Type (2016-2021)
14.3 Global Injectable Anticoagulants Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Injectable Anticoagulants Consumption Volume by Application (2016-2021)
15.2 Global Injectable Anticoagulants Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Injectable Anticoagulants Business
16.1 Sanofi
16.1.1 Sanofi Company Profile
16.1.2 Sanofi Injectable Anticoagulants Product Specification
16.1.3 Sanofi Injectable Anticoagulants Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Genentech (Roche)
16.2.1 Genentech (Roche) Company Profile
16.2.2 Genentech (Roche) Injectable Anticoagulants Product Specification
16.2.3 Genentech (Roche) Injectable Anticoagulants Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Boehringer Ingelheim
16.3.1 Boehringer Ingelheim Company Profile
16.3.2 Boehringer Ingelheim Injectable Anticoagulants Product Specification
16.3.3 Boehringer Ingelheim Injectable Anticoagulants Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Pfizer
16.4.1 Pfizer Company Profile
16.4.2 Pfizer Injectable Anticoagulants Product Specification
16.4.3 Pfizer Injectable Anticoagulants Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 The Medicines Company
16.5.1 The Medicines Company Company Profile
16.5.2 The Medicines Company Injectable Anticoagulants Product Specification
16.5.3 The Medicines Company Injectable Anticoagulants Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Aspen
16.6.1 Aspen Company Profile
16.6.2 Aspen Injectable Anticoagulants Product Specification
16.6.3 Aspen Injectable Anticoagulants Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Otsuka
16.7.1 Otsuka Company Profile
16.7.2 Otsuka Injectable Anticoagulants Product Specification
16.7.3 Otsuka Injectable Anticoagulants Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Injectable Anticoagulants Manufacturing Cost Analysis
17.1 Injectable Anticoagulants Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Injectable Anticoagulants
17.4 Injectable Anticoagulants Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Injectable Anticoagulants Distributors List
18.3 Injectable Anticoagulants Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Injectable Anticoagulants (2021-2027)
20.2 Global Forecasted Revenue of Injectable Anticoagulants (2021-2027)
20.3 Global Forecasted Price of Injectable Anticoagulants (2016-2027)
20.4 Global Forecasted Production of Injectable Anticoagulants by Region (2021-2027)
20.4.1 North America Injectable Anticoagulants Production, Revenue Forecast (2021-2027)
20.4.2 East Asia Injectable Anticoagulants Production, Revenue Forecast (2021-2027)
20.4.3 Europe Injectable Anticoagulants Production, Revenue Forecast (2021-2027)
20.4.4 South Asia Injectable Anticoagulants Production, Revenue Forecast (2021-2027)
20.4.5 Southeast Asia Injectable Anticoagulants Production, Revenue Forecast (2021-2027)
20.4.6 Middle East Injectable Anticoagulants Production, Revenue Forecast (2021-2027)
20.4.7 Africa Injectable Anticoagulants Production, Revenue Forecast (2021-2027)
20.4.8 Oceania Injectable Anticoagulants Production, Revenue Forecast (2021-2027)
20.4.9 South America Injectable Anticoagulants Production, Revenue Forecast (2021-2027)
20.4.10 Rest of the World Injectable Anticoagulants Production, Revenue Forecast (2021-2027)
20.5 Forecast by Type and by Application (2021-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2027)
20.5.2 Global Forecasted Consumption of Injectable Anticoagulants by Application (2021-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Injectable Anticoagulants by Country
21.2 East Asia Market Forecasted Consumption of Injectable Anticoagulants by Country
21.3 Europe Market Forecasted Consumption of Injectable Anticoagulants by Countriy
21.4 South Asia Forecasted Consumption of Injectable Anticoagulants by Country
21.5 Southeast Asia Forecasted Consumption of Injectable Anticoagulants by Country
21.6 Middle East Forecasted Consumption of Injectable Anticoagulants by Country
21.7 Africa Forecasted Consumption of Injectable Anticoagulants by Country
21.8 Oceania Forecasted Consumption of Injectable Anticoagulants by Country
21.9 South America Forecasted Consumption of Injectable Anticoagulants by Country
21.10 Rest of the world Forecasted Consumption of Injectable Anticoagulants by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer

Direct Purchase
Your perfect start with Stats And Research


Want to customize this report?

This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase.
RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo

You may also be lnterested in..

Stats And Research Copyright © 2021 .